Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. clinical proof of concept study
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Magazines
Downloads
Videos

Refine by
Date

  • Older

Clinical Proof Of Concept Study Articles & Analysis: Older

1,248 news found

Ace Therapeutics Releases Cardiovascular Disease Model Development Services to Power Up Related Preclinical Research

Ace Therapeutics Releases Cardiovascular Disease Model Development Services to Power Up Related Preclinical Research

Ace Therapeutics is proud to announce the launch of its cardiovascular disease model development services, aiming to empower researchers and pharmaceutical companies with advanced tools and models to accelerate the study of cardiovascular diseases and drug discovery. Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide, underscoring the urgent need for ...

ByAce Therapeutics


SOPHiA GENETICS Announces Expanded Partnership with Tennessee Oncology

SOPHiA GENETICS Announces Expanded Partnership with Tennessee Oncology

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that Tennessee Oncology, one of the United States’ largest community-based cancer care specialists that treats nearly half of Tennessee’s cancer patients across 35 clinics, has expanded its relationship with SOPHiA GENETICS to advance its cancer research. ...

BySOPHiA Genetics


SOPHiA GENETICS and Genomenon Collaborate to Streamline Genetic Research

SOPHiA GENETICS and Genomenon Collaborate to Streamline Genetic Research

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, today announced the next step in the partnership between the Company and Genomenon, a leading genomic intelligence company, to support better, data-driven outcomes in the rare disease and oncology fields. The two companies have expanded the integration of Genomenon’s Mastermind® Genomic ...

BySOPHiA Genetics


Liposomes for Food Applications

Liposomes for Food Applications

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is thrilled to announce the launch of its new line of liposomes specifically designed for food applications, offering promising delivery systems to enhance the bioavailability, stability, and taste of various food ingredients. In the field of food science, liposomes have attracted much attention ...

ByCD Bioparticles


SOPHiA Genetics Announces It Joins the European Liquid Biopsy Society at ECP 2024

SOPHiA Genetics Announces It Joins the European Liquid Biopsy Society at ECP 2024

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that the company is joining the European Liquid Biopsy Society (ELBS), a prestigious network consisting of partners from academia and industry with the common goal of making liquid biopsy tests part of the routine standard of care. SOPHiA GENETICS offers a ...

BySOPHiA Genetics


SOPHiA Genetics Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

SOPHiA Genetics Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an update from the Company’s work with biopharma company Boundless Bio. SOPHiA GENETICS first partnered with Boundless Bio in 2022 to develop and deploy Boundless Bio’s extrachromosomal DNA (ecDNA) detection algorithm as a clinical trial device, to ...

BySOPHiA Genetics


CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles

CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter and fluorescence channels. Various surface modifications, channels and sizes are also ...

ByCD Bioparticles


CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery

CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is proud to announce its expanded capabilities in Customized Liposomes. This advancement allows researchers and developers to leverage the power of liposome technology for a wider range of applications. Liposomes are small spherical artificial vesicles (typically 50-500 nm in diameter) composed ...

ByCD Bioparticles


Studying Flow-Induced Pulmonary Hypertension and Compensatory Lung Growth: Insights from A Novel Murine Model

Studying Flow-Induced Pulmonary Hypertension and Compensatory Lung Growth: Insights from A Novel Murine Model

In the realm of pulmonary research, the search to understand complex lung conditions has led to the development of various animal models. Among these, a new murine model from Tsijis et al stands out for its potential to investigate flow-induced pulmonary hypertension (PH) and compensatory lung growth (CLG). This blog outlines this innovative model, its significance, and the method of ...

BySCIREQ - an emka TECHNOLOGIES Company


CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials

CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials

CanaQuest Medical Corp (“CanaQuest” or the “Company”) (OTC: CANQF), is pleased to announce strategic additions to its executive team with expertise in conducting clinical trials and US FDA drug approval success. The team plans to effectively navigate the regulatory approval process for Drug Candidate, CQ-001 (cannabidiol + proprietary API composition), to treat rare ...

ByCanaQuest Medical Corp.


Comparison of the Rapid Bactericidal Efficacy of Commercially Available Surgical Solutions

Comparison of the Rapid Bactericidal Efficacy of Commercially Available Surgical Solutions

Introduction Intraoperative irrigation is a commonly used method aimed at reducing microbial burden by removing tissue debris, metabolic waste, and tissue exudate from the surgical field prior to site closure.1 With the absence of universally established standard of care and robust clinical data, the selection of appropriate irrigation solution remains a topic of debate. Isotonic saline has ...

BySanara MedTech Inc.


CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications

CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has recently expanded its low PDI polymer portfolio and announces its new offering of Polyolefin Family polymers with a wide range of properties that make them well-suited for a variety of drug delivery applications. Low dispersion index polymers are polymeric compounds with low molecular weight ...

ByCD Bioparticles


Biopharma Stock News Bite - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) Spikes on News Potential Treatment for Alcohol Use Disorder

Biopharma Stock News Bite - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) Spikes on News Potential Treatment for Alcohol Use Disorder

Investorideas.com (www.investorideas.com) Biotech Stock News Bites - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders made the NASDAQ Top ten percentage gainers today on news. The stock is trading at $2.0050, up $0.8750, gaining +77.0925% on volume of over 8o ...

ByInvestorideas.com


Dreams and Sleep Quality:  Finding the Best Anti-Snoring Device

Dreams and Sleep Quality: Finding the Best Anti-Snoring Device

Are you restless during sleep at night? Do you often wake up at night due to bad dreams or have difficulty in falling asleep? Are you anxious before you sleep? There are a variety of issues that can hamper proper and restful sleep at night, apart from snoring. According to University of Arizona clinical professor of medicine and dream specialist, Rubin Naiman, PhD, the two key components of good ...

ByTannerMedico A/S - Asonor


CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research

CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced an expanded portfolio of Polydimethylsiloxane (PDMS) products, empowering researchers with versatile and biocompatible tools for groundbreaking discoveries. Polydimethylsiloxane is an elastomeric polymer with interesting properties for biomedical applications, including ...

ByCD Bioparticles


ASMR for Sleep - Benefits and Snoring Solutions

ASMR for Sleep - Benefits and Snoring Solutions

Have you heard of the sensory phenomenon known as ASMR for sleep? ASMR stands for autonomous sensory meridian response, a condition, experience, or phenomenon that helps you fall asleep. As a form of parasthesia (a group or series of sensations felt in the skin), ASMR is perceived as a pleasant experience that is characterized by a tingling sensation in the neck and scalp areas that are ...

ByTannerMedico A/S - Asonor


AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the completion of patient enrollment in the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV). APEX-AV is a ...

ByAngioDynamics, Inc.


NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players

NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players

NHL Alumni Association (NHLAA), NEEKA Health Canada("NEEKA"),and CanaQuest Medical Corp ("CanaQuest") are pleased to announce a transformative study partnership that will investigate the efficacy of Mentanine® as a potential treatment to reduce anxiety in former NHL ...

ByCanaQuest Medical Corp.


CANAQUEST Announces Award of European Cannabinoid Patent

CANAQUEST Announces Award of European Cannabinoid Patent

We believe we can provide a safer alternative to other THC products providing the benefits without the negative psychiatric side effects. Pre-clinical trials have demonstrated the reversal of depression-like and schizophrenia-related symptoms, blockage of memory impairment, hyperactive activity, and gene vulnerability. CanaQuest Medical Corp ("CanaQuest" or the "Company") (OTC:CANQF), a ...

ByCanaQuest Medical Corp.


Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Investigational Pain Therapy Cebranopadol at the 2023 PAINWeek Conference

Tris Pharma Presents Data Reinforcing Limited Abuse Potential of Investigational Pain Therapy Cebranopadol at the 2023 PAINWeek Conference

Positive results confirm findings from prior studies evaluating the abuse potential of cebranopadol, further highlighting its potential as a safe and potent alternative to traditional opioids Registrational phase 3 clinical trials of cebranopadol in moderate to severe acute pain are on track to initiate in Q4 2023 – Business Wire – Tris Pharma, Inc. (Tris), a commercial-stage ...

ByTris Pharma, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT